TRIP13 and central nervous system cancer: We also found that the mRNA expression levels of TRIP13 were elevated in higher–grade glioma patients in microarray data (also validated by mRNA and protein assay) and demonstrated significantly poor prognosis in LGG and GBM patients from TCGA and CGGA data.